GLIAPHARM
GliaPharm is a Swiss-based biotechnology company that offers treatments for neurological and psychiatric disorders. GliaPharm's innovative therapeutic approach is to target glial cells , the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Their vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions. GliaPharm is a Swiss biotechnology company a... ctive in the development of treatments for neurological and psychiatric diseases. The innovative therapeutic approach of GliaPharm is to target glial cells , or 'support cells' of neurons, to support and improve brain metabolism under certain pathological conditions. Their vision is to become a leader in the development of glial cell targeting agents that act as neuroprotective agents and maintain cognitive functions.
GLIAPHARM
Social Links:
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.gliapharm.com
Total Employee:
11+
Status:
Active
Contact:
41 22 545 11 15
Email Addresses:
[email protected]
Total Funding:
2.18 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
FONGIT Innovation Fund
FONGIT Innovation Fund investment in Debt Financing - GliaPharm
Gliaven
Gliaven investment in Seed Round - GliaPharm
ACE & Company
ACE & Company investment in Seed Round - GliaPharm
MassChallenge
MassChallenge investment in Non Equity Assistance - GliaPharm
Official Site Inspections
http://www.gliapharm.com Semrush global rank: 4.85 M Semrush visits lastest month: 1.83 K
- Host name: h2web76.infomaniak.ch
- IP address: 83.166.138.22
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "GliaPharm"
Home - GliaPharm
Reimagine Brain Health - If you look at problems differently you can imagine different solutions. That’s what we’re doing. Based on pioneering insights into the essential role played by glial …See details»
About Us - GliaPharm
Magistretti co-founded GliaPharm as a spinoff of three decades of research performed in his laboratory at EPFL with the objectives to clinically apply fundamental discoveries he has …See details»
GliaPharm - Crunchbase Company Profile & Funding
GliaPharm is a Swiss-based biotechnology company that offers treatments for neurological and psychiatric disorders. GliaPharm's innovative therapeutic …See details»
GliaPharm SA - LinkedIn
GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders. GliaPharm's innovative therapeutic approach is to target glial cells, …See details»
GliaPharm 2025 Company Profile: Valuation, Funding & Investors
GliaPharm General Information Description. Developer of treatments and therapies intended to address neurological and psychiatric disorders. The company specializes in the research and …See details»
GliaPharm SA - BioAlps
GliaPharm’s innovative therapeutic approach is to target glial cells, the ‘support cells’ of neurons, to sustain and enhance brain metabolism in pathological conditions. Specialties. ...See details»
GliaPharm - Contacts, Employees, Board Members, Advisors
GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.See details»
GliaPharm SA - Swiss Biotech
GliaPharm is a Swiss biotechnology company developing treatments for neurological disorders. The company has developed a proprietary platform and pipeline of molecules targeting brain …See details»
Contact - GliaPharm
[email protected] +41 22 545 11 15; Geneva; Switzerland; Follow. Icon-linkedin ©GliaPharm, 2025 ...See details»
GliaPharm - VentureRadar
GliaPharm is a Swiss-based startup company that develops treatments for neurological and psychiatric disorders. Our company is a spinoff from a leading research laboratory at EPFL. …See details»
The Alzheimer’s Drug Discovery Foundation invests USD 4.2M in …
Dec 14, 2023 The ADDF will invest $4.2 million to bring GliaPharm’s lead compound GP-119 to the clinical stage. GP-119 is a novel orally active small molecule that acts on brain energy …See details»
GliaPharm - Funding, Financials, Valuation & Investors - Crunchbase
GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders. ... Log In. Log In. Experience the new Crunchbase, powered by AI . …See details»
GliaPharm SA | Alzheimer's Drug Discovery Foundation
Jan 8, 2024 GliaPharm is a Swiss-based biotech company that develops small molecules that target astrocytes to stimulate brain energy metabolism in neurological diseases. Astrocyte …See details»
GliaPharm SA - Genève, Switzerland - bionity.com
GliaPharm is a Swiss biotechnology company that develops treatments for neurological and psychiatric disorders. GliaPharm’s innovative therapeutic approach is to target glial cells, the …See details»
GliaXTM - GliaPharm
Technology Platform GliaXâ„¢ GliaPharm has established a proprietary drug discovery platform called GliaXâ„¢ to identify and characterize molecular targets and novel drug candidates that …See details»
Alzheimer Research: Gliapharm raises CHF 3.65 Million
May 8, 2025 GliaPharm SA, a biotech company that specializes in the research and development of novel therapies to treat and prevent neurological diseases, announces the …See details»
GliaPharm - EU-Startups
GliaPharm is a biotechnology business established in Switzerland that focuses on neurological and mental illnesses. In pathological settings, GliaPharm's novel treatment approach is to …See details»
Pipeline - GliaPharm
[email protected] +41 22 545 11 15; Geneva; Switzerland; Follow. Icon-linkedin ©GliaPharm, 2025. Pipeline Our novel drug candidates increase energy available to the brain by targeting …See details»
News - GliaPharm
Alzheimer’s disease: The Alzheimer’s Drug Discovery Foundation (ADDF) invests $4.2M in GliaPharm to advance its lead program Read more. Oct, 2022 Collaboration. UCB Read more. …See details»
Publications - GliaPharm
Publications Our research has been covered in leading peer-reviewed publications.Find out more below. 2024 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009See details»